Experimental Drug to Offer New Hope for Pediatric Brain Cancers

Tumors within the skull, whether benign or malignant, are particularly dreaded. They cause symptoms like headaches, seizures, nausea and vomiting, behavioral changes and unsteadiness. Benign tumors usually produce symptoms due to the pressure they exert on a part of the brain. An experimental drug, currently referred to as TA228, that is being investigated for the treatment of certain adult cancers, might possibly be useful in the treatment of two fatal brain cancers in children.